Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
New Drug Application
Biotech
Aldeyra preps for FDA refiling as dry eye drug hits ph. 3 goal
After an FDA rejection last year, Aldeyra has scored a(nother) phase 3 win for dry eye drug reproxalap.
Gabrielle Masson
Aug 8, 2024 10:48am
Vertex inches closer to acute pain market as FDA accepts VX-548
Apr 18, 2024 10:50am
Milestone resubmits NDA, Aldeyra readies 2nd chance filing
Mar 28, 2024 10:40am
Tonix signs CRO deal, preps FDA app for fibromyalgia drug
Feb 14, 2024 12:52pm
First-ever drug application for MDMA finally reaches FDA
Dec 13, 2023 9:39am
Karuna's new schizophrenia drug reaches FDA's desk
Sep 28, 2023 11:12am
